HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)
Drug Alias NameHIV clade B mRNA dendritic cell therapy
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionProtein Nef modulators
TargetsProtein Nef
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversite Libre De BruxellesImmunomic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A